MedTrace Logo

COVID-19 Vaccination in Oncologic Patients

NCT04918888 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1150

Last updated 2021-11-23

No results posted yet for this study

Summary

Evaluating the vaccination willingness in oncologic patients over six months as well as estimating the effects of radiotherapy/systemic anticancer treatment on the efficacy and toxicity of currently approved SARS-CoV-2 vaccines

Conditions

  • Covid19
  • Oncologic Disorders

Sponsors & Collaborators

  • Krankenhaus Barmherzige Schwestern Linz

    lead OTHER

Principal Investigators

  • Hans Geinitz, Univ.-Prof. · Ordensklinikum Linz GmbH, Barmherzige Schwestern

Eligibility

Min Age
18 Years
Max Age
120 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-19
Primary Completion
2021-09-30
Completion
2021-09-30

Countries

  • Austria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04918888 on ClinicalTrials.gov